
    
      Assessment of the 30-day mortality and major complications as well as the tumor size changes
      of the patients undergoing ipsilateral lobe arterial devascularization of the large
      hepatocellular carcinoma. This is a prospective non randomized trial carried out at the Ribat
      University Hospital between April 2017 to March 2018.
    
  